fda covid vaccine - Search News

Order byBest matchMost fresh

FDA, COVID-19 and vaccine

Top News

Overview

Impacts

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

Vaccine manufacturers will need to conduct "randomized, placebo-controlled trials" before the FDA will approve future applications to give shots to "all healthy persons" between the ages of 6 months ...

· 11h · on MSN

· 9h · on MSN

What to know about the FDA plan to restrict COVID vaccines

· 7h · on MSN

FDA announces plans to restrict access for COVID vaccines

WA vaccine scientists push back against FDA changes around COVID shots

Seattle vaccine experts were surprised and confused by the country’s apparent new direction around updated COVID-19 shots, which top officials at the Food and Drug Administration revealed Tuesday and ...

· 12h

· 23h

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

FDA sets new COVID booster guidelines for healthy adults under 65

Vaccine makers have argued that because COVID vaccines have been changed annually to match the circulating strain of the virus, new placebo-controlled trials could delay availability of the shots unt...

· 1d

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

Las Vegas Sun · 1d

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

1don MSN

FDA to limit covid shot approval to elderly, those with medical conditions

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

13hon MSN

Moderna withdraws application for COVID-flu combination vaccine

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration.

FDA Sets New COVID Booster Guidelines Requiring Trials for Approvals for Healthy Adults

FDA Commissioner Marty Makary and top U.S. vaccines regulator Vinay Prasad said based on data from tests that measure immune response in patients, they anticipate that the FDA will be able to approve the boosters for adults over the age of 65 years.

Explore more

United States

Food and Drug Administration

Novavax